PET PET
  • My Account
  • Subscribe
Become a Friend Donate
  • About Us
    • People
    • Press Office
    • Our History
  • Get Involved
    • Become a Friend of PET
    • Volunteer
    • Campaigns
    • Writing Scheme
    • Partnership and Sponsorship
    • Advertise with Us
  • Donate
    • Become a Friend of PET
  • BioNews
    • News
    • Comment
    • Reviews
    • Elsewhere
    • Topics
    • Glossary
    • Newsletters
  • Events
    • Upcoming Events
    • Previous Events
  • Engagement
    • Policy and Projects
      • Resources
    • Education
  • Jobs & Opportunities
  • Contact Us
  • About Us
    • People
    • Press Office
    • Our History
  • Get Involved
    • Become a Friend of PET
    • Volunteer
    • Campaigns
    • Writing Scheme
    • Partnership and Sponsorship
    • Advertise with Us
  • Donate
    • Become a Friend of PET
  • BioNews
    • News
    • Comment
    • Reviews
    • Elsewhere
    • Topics
    • Glossary
    • Newsletters
  • Events
    • Upcoming Events
    • Previous Events
  • Engagement
    • Policy and Projects
      • Resources
    • Education
  • Jobs & Opportunities
  • Contact Us
  • My Account
  • Subscribe
  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements
PETBioNewsNewsPGT-A did not improve live birth rate in clinic trial

BioNews

PGT-A did not improve live birth rate in clinic trial

Published 26 November 2021 posted in News and appears in BioNews 1123

Author

Ruth Retassie

Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.
CC0 1.0
Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.

A recent study found that preimplantation genetic testing for aneuploidy may not improve live birth rate...

A recent study found that preimplantation genetic testing for aneuploidy (PGT-A) may not improve live birth rate.

PGT-A is an add-on that many fertility clinics offer, due to the belief that not transferring aneuploid embryos will help to reduce miscarriage rate and improve live birth rate. Previous research had suggested that it could help improve live birth rate for older women but there was little research into how it impacted outcomes for young, healthy women. PGT-A is also potentially undesirable as it involves discarding aneuploid embryos, which can leave intended parents with fewer to have transferred than conventional IVF treatment.

Professor Richard Paulson director of USC Fertility in Los Angeles, California who was not involved in the research said: 'If you are someone who is in a good prognosis group ... and you have three blastocysts, it is in your best interest to not do the genetic testing.'

The research, detailed in the journal New England Journal of Medicine, was carried out across 14 fertility centres in China. The randomised, controlled trial involved 1212 subfertile women, ages 20-37, who had a good likelihood of having a live birth due to no history of recurring miscarriages or IVF cycles where the embryo had not implanted.

Split equally into two groups the trial looked at the live birth rate within a year and with up to three embryo transfers for women who had IVF with ICSI with PGT-A, and without PGT-A. They found similar rates between the two groups with a live birth rate of 85.3 percent for women whose embryos received PGT-A screening and 82.5 percent for women whose embryos did not.

A lower rate of miscarriage was found in the group who received PGT-A (8.7 percent compared to 12.6 percent), but more women in the conventional IVF group had second or third transfers of their embryos within a year, suggesting there were more embryos available for this group.

The authors of the study conclude that while PGT-A is not supported for women with a good prognosis, their results are not necessarily applicable to older women or women who have experienced multiple pregnancy loss or implantation failure. They also note they used ICSI for all women in the study which is not used for all IVF patients and that the results could be affected by their decision to not transfer mosaic embryos in the PGT-A group.

In a commentary that accompanied the piece Dr Sebastiaan Mastenbroek an embryologist from University Medical Centres in Amsterdam, the Netherlands and others who were not involved in the research noted: 'According to the 2018 Fertility Clinic Success Rates Report of the Centres for Disease Control and Prevention, PGT was used in 37.7 percent of all IVF cycles that resulted in an embryo transfer,' in the USA. He went on to point out that although the FDA does not regulate some fertility clinic 'add-ons' in the USA now, the public is calling for increased regulation. He warned the sector must be careful to innovate 'responsibility 'to avoid potential class-action lawsuits in future.

Sources and References

  • 25/11/2021
    New England Journal of Medicine
    Live birth with or without preimplantation genetic testing for aneuploidy list of authors.
  • 25/11/2021
    New England Journal of Medicine
    The imperative of responsible innovation in reproductive medicine
  • 24/11/2021
    Medpage Today
    Preimplantation genetic testing fails to improve IVF birth rates
  • 26/11/2021
    Physician's Weekly
    Pre-implantation genetic testing shows no birth rate benefit in IVF

Related Articles

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
Comment
7 March 2022 • 3 minutes read

Lawfully running a red light: a response from the HFEA

by Peter Thompson

In last week's BioNews, Julian Hitchcock argued that a recent statement from the Human Fertilisation and Embryology Authority on embryo selection needed clarification. I am happy to do that today...

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
Comment
28 February 2022 • 6 minutes read

Lawfully running a red light: aneuploidy testing

by Julian Hitchcock

In a recent press statement on the use of preimplantation genetic testing of human embryos, the HFEA stated that 'Embryo selection is only legal in the UK to avoid serious inherited illnesses, usually by means of pre-implantation genetic diagnosis authorised by the HFEA, known as PGT-M or PGT-SR'…

Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.
CC0 1.0
Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.
Comment
31 January 2022 • 8 minutes read

Adding Up What We Know: A Global Perspective on Fertility Treatment Add-Ons

by Sarah Norcross

There has been much professional and public debate about the use of so-called fertility treatment 'add-ons' over the years...

Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.
CC0 1.0
Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.
Comment
14 January 2022 • 5 minutes read

Immune 'add ons' in assisted reproduction

by Professor Ashley Moffett

One of the most difficult challenges for doctors treating women with infertility or recurrent miscarriage is that no cause is found in around 50 percent of cases...

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
Comment
6 December 2021 • 4 minutes read

PGT-A in young, good prognosis populations

by Dr Eric J Forman

A recent large randomised trial published in the New England Journal of Medicine is receiving significant attention with clinicians who are critical of preimplantation genetic testing for aneuploidy (PGT-A) claiming it provides evidence that PGT-A does not improve IVF outcomes and should not be used outside of research settings…

Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.
CC0 1.0
Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.
News
19 November 2021 • 2 minutes read

No difference in viability found between mosaic and non-mosaic embryos

by Tsvetana Stoilova

Many IVF embryos discarded due to chromosomal abnormalities could lead to viable pregnancies and healthy babies, a new non-selection clinical trial has suggested...

Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.
CC0 1.0
Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.
Comment
26 July 2021 • 4 minutes read

IVF add-ons: are they supported by evidence?

by Sarah Lensen

IVF add-ons are procedures, techniques or medicines which can be used in addition to standard IVF protocols. They are usually offered by IVF clinics, and used by patients, with the hope that they will improve the chance of IVF success...

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
28 May 2021 • 2 minutes read

Embryos often develop into healthy babies despite aneuploid genetic tests

by Dr Katie Howe

Some of the faulty embryos currently ruled out for use in IVF can self-correct and lead to healthy pregnancies, research has revealed..

Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.
CC0 1.0
Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.
News
10 August 2018 • 3 minutes read

Genetic screening of embryos makes no difference to births

by Charlott Repschläger

Pre-implantation genetic testing of embryos does not improve IVF birth rates in older women, found the largest study of its kind yet...

Leave a Reply Cancel reply

You must be logged in to post a comment.

« Cancer cells grow by sucking mitochondria out of immune cells

Data-Label The UK's Leading Supplier Of Medical Labels & Asset Labels

RetiringDentist.co.uk The UK's Leading M&A Company.
easyfundraising
amazon

This month in BioNews

  • Popular
  • Recent
13 June 2022 • 2 minutes read

Drop in diversity of blood stem cells leads to old-age health issues

27 June 2022 • 2 minutes read

UK report reveals public attitudes to fertility, genomics and embryo research

27 June 2022 • 2 minutes read

Shortage of sperm donors despite men willing to donate

27 June 2022 • 2 minutes read

North East London CCG proposes offering three funded IVF cycles

27 June 2022 • 2 minutes read

Fibrosis drugs reverse ovarian ageing in mice

27 June 2022 • 2 minutes read

Gene implicated in motor neurone diseases discovered

Subscribe to BioNews and other PET updates for free.

Subscribe
  • Twitter
  • Facebook
  • Instagram
  • LinkedIn
  • YouTube
  • RSS
Wellcome
Website redevelopment supported by Wellcome.

Website by Impact Media Impact Media

  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements

© 1992 - 2022 Progress Educational Trust. All rights reserved.

Limited company registered in England and Wales no 07405980 • Registered charity no 1139856

Subscribe to BioNews and other PET updates for free.

Subscribe
PET PET

PET is an independent charity that improves choices for people affected by infertility and genetic conditions.

  • Twitter
  • Facebook
  • Instagram
  • LinkedIn
  • YouTube
  • RSS
Wellcome
Website redevelopment supported by Wellcome.

Navigation

  • About Us
  • Get Involved
  • Donate
  • BioNews
  • Events
  • Engagement
  • Jobs & Opportunities
  • Contact Us

BioNews

  • News
  • Comment
  • Reviews
  • Elsewhere
  • Topics
  • Glossary
  • Newsletters

Other

  • My Account
  • Subscribe

Website by Impact Media Impact Media

  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements

© 1992 - 2022 Progress Educational Trust. All rights reserved.

Limited company registered in England and Wales no 07405980 • Registered charity no 1139856